EMD Serono, Inc. drugs
4 results
Bavencio (avelumab)
(avelumab)EMD Serono, Inc.
Usage: BAVENCIO (avelumab) is indicated for adults and patients aged 12 and older with metastatic Merkel cell carcinoma. It also treats locally advanced or metastatic urothelial carcinoma, both as first-line maintenance after chemotherapy and for previously-treated cases, and is used in combination with axitinib for advanced renal cell carcinoma.
Mavenclad (cladribine)
(Cladribine)EMD Serono, Inc.
Usage: MAVENCLAD is indicated for treating relapsing forms of multiple sclerosis (MS) in adults, including relapsing-remitting and active secondary progressive diseases. It is generally recommended for patients who have inadequate responses to or cannot tolerate other MS therapies. Not recommended for clinically isolated syndrome (CIS).
Rebif (interferon beta-1a)
(interferon beta-1a)EMD Serono, Inc.
Usage: REBIF is indicated for treating relapsing forms of multiple sclerosis (MS) in adults, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
Tepmetko (tepotinib hydrochloride)
(Tepotinib Hydrochloride)EMD Serono, Inc.
Usage: TEPMETKO is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) that has mesenchymal-epithelial transition (MET) exon 14 skipping alterations.